Legal Representation
Attorney
Cheryl A. Withycombe
USPTO Deadlines
Application History
36 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 22, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Apr 22, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Apr 22, 2025 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
Apr 4, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 19, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 18, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
Dec 18, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
Sep 19, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Sep 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 19, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Sep 16, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Sep 16, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 16, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Sep 16, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jul 14, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
Jul 14, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jul 14, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
Jul 14, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Jul 14, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
Jul 14, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jul 14, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jan 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Nov 14, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 14, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 25, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 9, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 9, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Oct 9, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 9, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 9, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Oct 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 2, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Aug 1, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jul 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
providing information about medical clinical trials, namely, information in the field of improving diversity and inclusion in clinical research studies and clinical trials.
First Use Anywhere:
Jan 31, 2023
First Use in Commerce:
Jan 31, 2023
Additional Information
Design Mark
The mark consists of The word "admire" with stylized parenthesis on both sides that appear as half circle shapes.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042